BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21518536)

  • 1. [Multi-state Markov model in expressing the outcome of mild cognitive impairment among community-based elderly residents].
    Yang SS; Zhou LY; Liang RF; Luo TE; Qu CY; Yu HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jan; 32(1):25-8. PubMed ID: 21518536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-state Markov model in outcome of mild cognitive impairments among community elderly residents in Mainland China.
    Yu HM; Yang SS; Gao JW; Zhou LY; Liang RF; Qu CY
    Int Psychogeriatr; 2013 May; 25(5):797-804. PubMed ID: 23286508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multi-state model in the evaluation of outcome on mild cognitive impairment to Alzheimer's disease].
    Gao JW; Yang SS; Zhou LY; Wang XC; Gao CH; Song PP; Yu HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):470-3. PubMed ID: 22883171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Competing risk model based study of outcomes of mild cognitive impairment of seniors].
    Sun Q; Song Y; Kong P; Yu H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Mar; 36(3):241-4. PubMed ID: 25975401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic transitions in mild cognitive impairment subtypes.
    Forlenza OV; Diniz BS; Nunes PV; Memória CM; Yassuda MS; Gattaz WF
    Int Psychogeriatr; 2009 Dec; 21(6):1088-95. PubMed ID: 19691909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The assessment of changes in cognitive functioning in the elderly: age- and education-specific reliable change indices for the SIDAM.
    Stein J; Luppa M; Maier W; Tebarth F; Heser K; Scherer M; Zimmermann T; Eisele M; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Wiese B; Prokein J; König HH; Leicht H; Riedel-Heller SG;
    Dement Geriatr Cogn Disord; 2012; 33(2-3):73-83. PubMed ID: 22414525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment in instrumental activities of daily living with high cognitive demand is an early marker of mild cognitive impairment: the Sydney memory and ageing study.
    Reppermund S; Brodaty H; Crawford JD; Kochan NA; Draper B; Slavin MJ; Trollor JN; Sachdev PS
    Psychol Med; 2013 Nov; 43(11):2437-45. PubMed ID: 23308393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premorbid IQ influence on screening tests' scores in healthy patients and patients with cognitive impairment.
    Alves L; Simões MR; Martins C; Freitas S; Santana I
    J Geriatr Psychiatry Neurol; 2013 Jun; 26(2):117-26. PubMed ID: 23584853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early Mental Test--developing a screening test for mild cognitive impairment].
    Kálmán J; Pákáski M; Hoffmann I; Drótos G; Darvas G; Boda K; Bencsik T; Gyimesi A; Gulyás Z; Bálint M; Szatlóczki G; Papp E
    Ideggyogy Sz; 2013 Jan; 66(1-2):43-52. PubMed ID: 23607229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of education on the progression of early- versus late-stage mild cognitive impairment.
    Ye BS; Seo SW; Cho H; Kim SY; Lee JS; Kim EJ; Lee Y; Back JH; Hong CH; Choi SH; Park KW; Ku BD; Moon SY; Kim S; Han SH; Lee JH; Cheong HK; Na DL
    Int Psychogeriatr; 2013 Apr; 25(4):597-606. PubMed ID: 23207181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TeLPI performance in subjects with mild cognitive impairment and Alzheimer disease: a validation study.
    Alves L; Simões MR; Martins C; Freitas S; Santana I
    Alzheimer Dis Assoc Disord; 2013; 27(4):324-9. PubMed ID: 23314065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study.
    Wagg A; Dale M; Tretter R; Stow B; Compion G
    Eur Urol; 2013 Jul; 64(1):74-81. PubMed ID: 23332882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment.
    Rozzini L; Chilovi BV; Bertoletti E; Conti M; Del Rio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2006 Jun; 21(6):550-5. PubMed ID: 16642542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?
    Ball J; Carrington MJ; Stewart S;
    Heart; 2013 Apr; 99(8):542-7. PubMed ID: 23315607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
    Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
    J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Cognitive Assessment Battery (CAB): a rapid test of cognitive domains.
    Nordlund A; Påhlsson L; Holmberg C; Lind K; Wallin A
    Int Psychogeriatr; 2011 Sep; 23(7):1144-51. PubMed ID: 21251350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular cognitive disorders and depression after first-ever stroke: the Fogarty-Mexico Stroke Cohort.
    Arauz A; Rodríguez-Agudelo Y; Sosa AL; Chávez M; Paz F; González M; Coral J; Díaz-Olavarrieta C; Román GC
    Cerebrovasc Dis; 2014; 38(4):284-9. PubMed ID: 25412708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women.
    Winkler A; Dlugaj M; Weimar C; Jöckel KH; Erbel R; Dragano N; Moebus S
    J Alzheimers Dis; 2014; 42(4):1269-77. PubMed ID: 25024326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition performance differentiates between elderly patients in the long term course of secondary progressive multiple sclerosis and amnestic mild cognitive impairment.
    Müller S; Saur R; Greve B; Melms A; Hautzinger M; Fallgatter AJ; Leyhe T
    Mult Scler; 2013 May; 19(6):799-805. PubMed ID: 23166118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants, MRI correlates, and prognosis of mild cognitive impairment: the Rotterdam Study.
    de Bruijn RF; Akoudad S; Cremers LG; Hofman A; Niessen WJ; van der Lugt A; Koudstaal PJ; Vernooij MW; Ikram MA
    J Alzheimers Dis; 2014; 42 Suppl 3():S239-49. PubMed ID: 24825566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.